A cheaper, easier-to-use version of Wegovy is coming to the US soon

Tech Insider : Business
overweight person with a pill and water
Wegovy's new pill (not pictured) has been approved in the US, offering a needle-free option with a lower starting price than injections.

colnihko/Getty Images

Why cheap copycat Ozempic is still everywhere

Tech Insider : Economy, Business
Sleazy dealer wearing an open jacket, revealing counterfeit Ozempic pens in his pocket.

Getty Images; Alyssa Powell/BI

The copycat weight-loss drugs party was supposed to be over, but it's still raging on.

OpenAI just created one of the richest charities in the world

Tech Insider : Business, Technology
Sam Altman is holding a microphone in his right hand and gesturing with his left hand.
OpenAI CEO Sam Altman said on Monday that the X and Reddit posts on AI feel "very fake in a way it really didn't a year or two ago."

Andrew Harnik via Getty Images

Here's what Big Pharma could buy in 2025, from obesity drugs to precision cancer treatments, according to a top M&A banker

Tech Insider : Business
Red pills with $100 bills wrapped around them.
Chris Roop, head of M&A for the Americas at investment bank Jefferies, said Big Pharma will be looking for new drugs to boost growth in 2025.

GP Kidd/Getty Images

5 new weight-loss drugs to watch in the fight for the next Ozempic

Tech Insider
A pill
The race is on to make a weight-loss pill that is as effective as injectables like Ozempic, Wegovy, Mounjaro, and Zepbound.

Getty Images

Weight-loss drugs are life-changing — and expensive. Here's one woman's solution.

Tech Insider
Portrait image of Tara Rothenhoefer
Tara Rothenhoefer has been taking tirzepatide for more than four years, and only in the past six months has she felt secure in having an affordable supply.

Octavio Jones for BI

Eli Lilly's Wegovy rival Zepbound will help make weight-loss drug market worth $130 billion by 2030, Goldman Sachs says

Tech Insider
Zepbound
Zepbound is Eli Lilly's new weight-loss drug.

Brendan McDermid/Reuters

2 major employers said they stopped paying for weight-loss drugs like Wegovy after the drugmaker threatened to penalize them

Tech Insider
A wegovy pen in shadow

Michael Siluk/UCG/Universal Images Group via Getty Images; BI

Healthcare companies are promising to help patients quit Wegovy. There's just one problem with that.

Tech Insider
Illustration of person and Ozempic pen.

Cornelia Li for Business Insider

Ozempic maker plans manufacturing blitz as market for the drug is expected to top $100 billion in 2030

Tech Insider
woman holding ozempic pen

Getty Images

Subscribe to novo-nordisk